<PAPER><mode2 name='PMC4677697' hasDoc='yes' version='597'></mode2><article xmlns:mml='http://www.w3.org/1998/Math/MathML' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:ali='http://www.niso.org/schemas/ali/1.0' article-type='research-article'><front><journal-meta><journal-id journal-id-type='nlm-ta'>Dement Geriatr Cogn Dis Extra</journal-id><journal-id journal-id-type='iso-abbrev'>Dement Geriatr Cogn Dis Extra</journal-id><journal-id journal-id-type='publisher-id'>DEE</journal-id><journal-title-group><journal-title>Dementia and Geriatric Cognitive Disorders EXTRA</journal-title></journal-title-group><issn pub-type='ppub'>1664-5464</issn><issn pub-type='epub'>1664-5464</issn><publisher><publisher-name>S. Karger AG</publisher-name><publisher-loc>Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH–4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.ch</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type='pmcid'>4677697</article-id><article-id pub-id-type='doi'>10.1159/000441184</article-id><article-id pub-id-type='publisher-id'>dee-0005-0442</article-id><article-categories><subj-group subj-group-type='heading'><subject>Original Research Article</subject></subj-group></article-categories><title-group><article-title><s sid='1'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1>Clinical and Cognitive Phenotype of Mild Cognitive Impairment Evolving to Dementia with Lewy Bodies</s></article-title></title-group><contrib-group><contrib contrib-type='author'><name><surname>Cagnin</surname><given-names>Annachiara</given-names></name><xref rid='aff1' ref-type='aff'>a</xref><xref rid='aff2' ref-type='aff'>b</xref><xref rid='cor1' ref-type='corresp'>*</xref></contrib><contrib contrib-type='author'><name><surname>Bussè</surname><given-names>Cinzia</given-names></name><xref rid='aff1' ref-type='aff'>a</xref></contrib><contrib contrib-type='author'><name><surname>Gardini</surname><given-names>Simona</given-names></name><xref rid='aff3' ref-type='aff'>c</xref><xref rid='aff4' ref-type='aff'>d</xref></contrib><contrib contrib-type='author'><name><surname>Jelcic</surname><given-names>Nela</given-names></name><xref rid='aff1' ref-type='aff'>a</xref><xref rid='aff2' ref-type='aff'>b</xref></contrib><contrib contrib-type='author'><name><surname>Guzzo</surname><given-names>Caterina</given-names></name><xref rid='aff3' ref-type='aff'>c</xref><xref rid='aff4' ref-type='aff'>d</xref></contrib><contrib contrib-type='author'><name><surname>Gnoato</surname><given-names>Francesca</given-names></name><xref rid='aff1' ref-type='aff'>a</xref></contrib><contrib contrib-type='author'><name><surname>Mitolo</surname><given-names>Micaela</given-names></name><xref rid='aff2' ref-type='aff'>b</xref></contrib><contrib contrib-type='author'><name><surname>Ermani</surname><given-names>Mario</given-names></name><xref rid='aff1' ref-type='aff'>a</xref></contrib><contrib contrib-type='author'><name><surname>Caffarra</surname><given-names>Paolo</given-names></name><xref rid='aff3' ref-type='aff'>c</xref><xref rid='aff4' ref-type='aff'>d</xref></contrib></contrib-group><aff id='aff1'><sup>a</sup>Department of Neurosciences, University of Padova, Padova, Italy</aff><aff id='aff2'><sup>b</sup>IRCCS San Camillo Research Hospital, Venice, Italy</aff><aff id='aff3'><sup>c</sup>Department of Neuroscience, University of Parma, Italy</aff><aff id='aff4'><sup>d</sup>Center for Cognitive Disorders, AUSL of Parma, Parma, Italy</aff><author-notes><corresp id='cor1'>*Annachiara Cagnin, Department of Neurosciences, University of Padova Medical School, Via Giustiniani 5, IT-35128 Padova (Italy), E-Mail <email>annachiara.cagnin@unipd.it</email></corresp></author-notes><pub-date pub-type='collection'><season>Sep-Dec</season><year>2015</year></pub-date><pub-date pub-type='epub'><day>24</day><month>11</month><year>2015</year></pub-date><pub-date pub-type='pmc-release'><day>24</day><month>11</month><year>2015</year></pub-date><volume>5</volume><issue>3</issue><fpage>442</fpage><lpage>449</lpage><permissions><copyright-statement>Copyright © 2015 by S. Karger AG, Basel</copyright-statement><copyright-year>2015</copyright-year><license license-type='open-access' xlink:href='http://creativecommons.org/licenses/by-nc-nd/4.0/'><license-p>This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission.</license-p></license></permissions><abstract><sec><title>Objective</title><p><s sid='2'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1>The aim of this study was to determine which characteristics could better distinguish dementia with Lewy bodies (DLB) from Alzheimer's disease (AD) at the mild cognitive impairment (MCI) stage, with particular emphasis on visual space and object perception abilities.</s></p></sec><sec><title>Methods</title><p><s sid='3'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>Fifty-three patients with mild cognitive deficits that were eventually diagnosed with probable DLB (MCI-DLB: n = 25) and AD (MCI-AD: n = 28) at a 3-year follow-up were retrospectively studied.</s><s sid='4'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> At the first visit, the patients underwent cognitive assessment including the Qualitative Scoring Mini Mental State Examination Pentagon Test and the Visual Object and Space Perception Battery.</s><s sid='5'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The Neuropsychiatric Inventory Questionnaire, Unified Parkinson's Disease Rating Scale (UPDRS) and questionnaires for cognitive fluctuations and sleep disorders were also administered.</s></p></sec><sec><title>Results</title><p><s sid='6'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>The best clinical predictor of DLB was the presence of soft extrapyramidal signs (mean UPDRS score: 4.04 ± 5.9) detected in 72% of patients, followed by REM sleep behavior disorder (60%) and fluctuations (60%).</s><s sid='7'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Wrong performances in the pentagon's number of angles were obtained in 44% of DLB and 3.7% of AD patients and correlated with speed of visual attention.</s><s sid='8'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Executive functions, visual attention and visuospatial abilities were worse in DLB, while verbal episodic memory impairment was greater in AD.</s><s sid='9'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Deficits in the visual-perceptual domain were present in both MCI-DLB and AD.</s></p></sec><sec><title>Conclusions</title><p><s sid='10'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1>Poor performance in the pentagon's number of angles is specific of DLB and correlates with speed of visual attention.</s><s sid='11'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> The dorsal visual stream seems specifically more impaired in MCI-DLB with respect to the ventral visual stream, the latter being involved in both DLB and AD.</s><s sid='12'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> These cognitive features, associated with subtle extrapyramidal signs, should alert clinicians to a diagnostic hypothesis of DLB.</s></p></sec></abstract><kwd-group><title>Key Words</title><kwd>Dementia with Lewy bodies</kwd><kwd>Visuoconstructional abilities</kwd><kwd>Mini Mental State Examination</kwd><kwd>Mild cognitive impairment</kwd></kwd-group><counts><fig-count count='1'></fig-count><table-count count='1'></table-count><ref-count count='22'></ref-count><page-count count='8'></page-count></counts></article-meta></front><body><sec sec-type='intro' id='sec1_1'><title>Introduction</title><p><s sid='13'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>Although a distinct cognitive profile in patients with dementia with Lewy bodies (DLB) and dementia due to Alzheimer's disease (AD) has been extensively demonstrated (worse memory domain in AD and attentional/visuospatial domain in DLB), only few studies have addressed the same topic in the prodromal stage of these diseases using extensive and comprehensive cognitive tools [<xref rid='B1' ref-type='bibr'>1</xref>,<xref rid='B2' ref-type='bibr'>2</xref>,<xref rid='B3' ref-type='bibr'>3</xref>].</s></p><p><s sid='14'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>The pentagon copying of the Mini Mental State Examination (MMSE) was investigated for the first time in DLB and AD patients [<xref rid='B4' ref-type='bibr'>4</xref>], then updated with an analytic approach and validated in a neuropathologically proven DLB cohort [<xref rid='B5' ref-type='bibr'>5</xref>,<xref rid='B6' ref-type='bibr'>6</xref>].</s><s sid='15'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> In the study by Ala et al. [<xref rid='B4' ref-type='bibr'>4</xref>], an unacceptable pentagon copy reached an 88% sensitivity and a 58% specificity in discriminating the two conditions.</s><s sid='16'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> It was also recognized that this feature could be better captured in the early stages of the diseases, and it was suggested that it may be independent of other well-recognized diagnostic characteristics of DLB.</s><s sid='17'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> On this line, a previous study from our group demonstrated that a reduced number of angles of the MMSE pentagon copy could be a marker of prodromal DLB with a specificity of 91% in the discrimination with prodromal AD, suggesting that visuoconstructional impairment may serve as an early cognitive marker of DLB [<xref rid='B7' ref-type='bibr'>7</xref>].</s><s sid='18'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> In a neuropathologically confirmed study, it has been shown that in the prodromal stage of DLB, the performance in visual attention was worse than in AD [<xref rid='B3' ref-type='bibr'>3</xref>].</s></p><p><s sid='19'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1>To our knowledge there are no studies assessing the subfield of visuospatial and perceptual abilities in the mild cognitive impairment (MCI) stage due to DLB.</s><s sid='20'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1> Thus, the aim of this study was to determine which clinical and cognitive characteristics could help better identify MCI patients evolving to DLB from those evolving to AD, with particular emphasis on visual space and object perception deficits.</s></p></sec><sec sec-type='subjects|methods' id='sec1_2'><title>Patients and Methods</title><p><s sid='21'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>Patients were enrolled and studied at the neurological departments of the Universities of Padova and Parma (Italy).</s><s sid='22'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1> Twenty-five patients with mild cognitive deficits in the predementia stage that were eventually diagnosed with probable DLB at the follow-up visits (MCI-DLB) and 28 patients with mild cognitive deficits ultimately diagnosed as probable AD (MCI-AD) were included in the study.</s><s sid='23'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The charts of the patients were retrospectively evaluated, and data from clinical and neuropsychological assessments at the first visit (time of predementia stage) were evaluated by dementia experts not involved in the patients' assessments.</s><s sid='24'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> Inclusion criteria were: absence of dementia (cutoff MMSE score &gt;26/30) and of functional impairment in everyday life at the first visit, and clinical information available from the first visit to the follow-up visits until a definite clinical diagnosis of probable DLB or AD was reached according to current diagnostic criteria [<xref rid='B8' ref-type='bibr'>8</xref>,<xref rid='B9' ref-type='bibr'>9</xref>] after at least 3 years of follow-up.</s><s sid='25'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> Exclusion criteria were: inability to establish a definite diagnosis at the follow-up visits and cognitive decline due to comorbidities.</s></p><p><s sid='26'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1>At the first assessment, the patients underwent full clinical history and neurological evaluation including screening for extrapyramidal signs with the Unified Parkinson's Disease Rating Scale (UPDRS) motor score [<xref rid='B10' ref-type='bibr'>10</xref>], assessment of behavioral disorders with the Neuropsychiatric Inventory Questionnaire [<xref rid='B11' ref-type='bibr'>11</xref>], presence of fluctuations in cognition and attention using the Mayo Fluctuation Questionnaire [<xref rid='B12' ref-type='bibr'>12</xref>] and presence of symptoms suggestive of REM sleep behavior disorder (RBD) by the Mayo Sleep Questionnaire [<xref rid='B13' ref-type='bibr'>13</xref>].</s></p><p><s sid='27'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1>Baseline neuropsychological evaluation was obtained for each patient by experienced neuropsychologists (N.J., F.G., S.G., C.G.).</s><s sid='28'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Global cognitive performance was assessed using the MMSE test.</s><s sid='29'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Each pentagon drawing of the MMSE test was retrospectively examined with the Qualitative Scoring MMSE Pentagon Test (QSPT) [<xref rid='B5' ref-type='bibr'>5</xref>] by a neuropsychologist (C.B. or M.M.) not involved in the formal cognitive assessment and blind to the diagnosis.</s><s sid='30'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The QSPT scoring method includes the following 5 criteria of judgment: (1) number of angles; (2) distance/intersection between the two figures; (3) closing/opening of the contour (the figure is considered closed even when two sides do not touch each other as long as the distance is ≤1 mm); (4) rotation of one or both pentagons (when there is no figure or the figure is not a pentagon, then the rotation is not assessable; when the rotation is less than 45°, the figure is not considered rotated); (5) closing-in and a total score corresponding to the sum of individual scores of each parameter, ranging from 0 to 13.</s><s sid='31'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> For each parameter an arbitrary score was assigned, where zero indicated the worst performance.</s><s sid='32'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> Tremor is ignored.</s><s sid='33'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> When participants executed more than 1 copy of pentagons, the best copy was graded.</s></p><p><s sid='34'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>Specific cognitive domains were investigated using the following neuropsychological tests: digit cancellation and Trail Making Test A for the evaluation of visual attention; digit span forward and backward for short-term memory; prose memory (immediate and delayed recall) test for long-term memory; letter fluency test for the study of word generation and executive functioning; clock drawing test for visuoconstructional abilities and executive functions; Rey-Osterrieth Complex Figure (ROCF) test for the assessment of visuoconstructional abilities (ROCF copy) and long-term visual-spatial memory (ROCF delayed recall) [<xref rid='B14' ref-type='bibr'>14</xref>].</s></p><p><s sid='35'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>The Visual Object and Space Perception (VOSP) battery was administered to all patients in order to assess visual-perceptual and visual-spatial impairments [<xref rid='B15' ref-type='bibr'>15</xref>].</s><s sid='36'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The VOSP is a neuropsychological battery composed of a screening test, 4 subtests for object perception and 4 subtests for space perception.</s><s sid='37'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The screening test, evaluating figure/ground perception, includes 20 squares with random patterns, on half of which a degraded ‘X’ is inserted.</s><s sid='38'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> The subject is asked to judge whether the ‘X’ is present or not (maximum score 20).</s><s sid='39'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> For object perception, in the fragmented letters task (subtest 1), the subject has to recognize 20 degraded capital letters (maximum score = 20); in the silhouettes task (subtest 2), the subject is asked to identify 30 black silhouettes presented in an unusual view (maximum score = 30); in the object decision task (subtest 3), the subject has to judge which of the 4 drawings represents a real object, while the 3 other objects are nonsense drawings (maximum score = 20); in the progressive silhouettes task (subtest 4), 2 series of 10 drawings progressively easier to be identified were presented (maximum score = 20).</s><s sid='40'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> For space perception, the dot counting subtest (subtest 5) is composed by 10 arrays of black dots, and the subject has to count the number of dots in each item (maximum score = 10); in the position discrimination task (subtest 6), 2 squares are presented, one with a black dot printed in the center and the other one with a black dot printed out of the center: the subject has to point to the dot perceived in the center of the square (maximum sore = 20); in the number location task (subtest 7), each item consists of 2 squares, one containing a random pattern of numbers and the other one containing a single black dot, corresponding to the position of one of the numbers: the subject has to point to the number that corresponds to the position of the dot (maximum score = 10); in the cube analysis (subtest 8), the subject has to count how many solid bricks there are in a series of drawings, each representing a tridimensional structure of bricks (maximum score = 10).</s></p><p><s sid='41'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>The Student t test for independent groups was used for the analysis of normally distributed variables, the Mann-Whitney U test for ordinal variables and the χ<sup>2</sup> test for categorical variables.</s><s sid='42'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Linear correlations between the cognitive test scores were tested using Spearman's ρ correlation coefficient.</s><s sid='43'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Logistic regression model analysis was used to find the independent cognitive variables related to the diagnosis.</s><s sid='44'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The significance level was set at p &lt; 0.05.</s></p><p><s sid='45'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>The study received approval by the institutional review board, and all patients signed informed consent.</s></p></sec><sec sec-type='results' id='sec1_3'><title>Results</title><p><s sid='46'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>At the MCI stage, the DLB and AD groups were matched for age (DLB: 76.5 ± 4.9 years, age range: 67-86; AD: 73.4 ± 6.7 years, age range: 57-83; p = 0.06), gender (male/female = DLB: 14/11; AD: 16/12; p = 0.9) and education (DLB: 9.3 ± 4.5 years; AD: 11.4 ± 4.7 years; p = 0.11).</s><s sid='47'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> In the DLB group, the presence of visual hallucinations was reported in 9/25 patients (36%), fluctuations of cognition and alertness in 60% (15/25) and RBD in 60% (15/25).</s><s sid='48'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> In the AD group, 1 patient had visual hallucinations, and none manifested fluctuations or RBD.</s></p><p><s sid='49'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>Presence of extrapyramidal signs was the most frequent supportive feature detected in 18/25 DLB patients (72%), although often subtle (mean UPDRS score: 4.04 ± 5.9), with 13/18 patients with UPDRS score ≤5.</s><s sid='50'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Only 4/24 (17%) patients with prodromal AD showed subtle extrapyramidal signs (mean UPDRS score: 0.25 ± 0.64).</s></p><p><s sid='51'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>Neuropsychological test results of the MCI-DLB and MCI-AD groups are reported in table <xref rid='T1' ref-type='table'>1</xref>.</s><s sid='52'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> The mean MMSE score was 27.8 ± 1.3 for DLB and 27.2 ± 1.3 for AD (p = 0.07).</s><s sid='53'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> In the QSPT, the score for number of angles was significantly lower in the DLB patients (p = 0.01).</s><s sid='54'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> An impaired number of angles (angle item score &lt;4) was present in 44% (11/25) of DLB patients compared to 3.7% (1/27) of AD (p &lt; 0.001).</s><s sid='55'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> No significant difference was found for the total QSPT score and its remaining subscores.</s></p><p><s sid='56'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>Patients of the DLB group showed greater impairment than those with AD in speed of visual attention (Trail Making Test A, p = 0.03), working memory (digit span backward, p = 0.001) and executive functions (verbal fluency, p = 0.002).</s><s sid='57'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> AD patients, instead, showed greater impairment in verbal episodic memory, with lower scores in prose memory delayed recall (p = 0.02).</s></p><p><s sid='58'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>As for visuospatial abilities investigated with the VOSP battery, patients with MCI-DLB presented with significantly more severe visuoconstructional deficits (cube analysis subtest) and visual-attentional deficits (number location subtest) than AD patients (table <xref rid='T1' ref-type='table'>1</xref>).</s><s sid='59'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Deficits in the visuoperceptual domain were detected in MCI-DLB as well as in MCI-AD, particularly in the fragmented letters, silhouettes and object decision items, and therefore did not appear to be disease specific, although more DLB patients than AD patients scored below the cutoff value of normality (i.e. silhouette item &lt;cutoff value = DLB: 72%, AD: 43%) (fig. <xref rid='F1' ref-type='fig'>1</xref>).</s></p><p><s sid='60'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>The QSPT score for number of angles correlated positively with the Trail Making Test A test score (r = −0.34, p = 0.01) and cube analysis of VOSP (r = 0.28, p = 0.04), and negatively with the prose memory immediate recall test score (r = −0.36, p = 0.008) in the whole sample.</s><s sid='61'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> The QSPT scores for number of angles restricted to the DLB group correlated negatively only with the prose memory immediate recall (p = 0.01).</s></p><p><s sid='62'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>In the multivariate analysis using a logistic regression model, we considered only the test scores that were significantly different between DLB and AD (p ≤ 0.01): number of pentagon angles, digit backward, verbal fluency and cube analysis of the VOSP battery.</s><s sid='63'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> The results of this analysis showed that only the score for number of pentagon angles and the digit backward test score remained significantly correlated with the diagnosis.</s><s sid='64'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Using both the score for number of angles and the digit backward tests score, the specificity (88%) and sensitivity (54%) of the differential diagnosis did not change significantly with respect to using only the number of angles (specificity 96%, sensitivity 42%).</s><s sid='65'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> The positive predictive value was 81% using both variables and 91% using only the score for number of angles, while the negative predictive value was 67% and 63%, respectively.</s></p></sec><sec sec-type='discussion' id='sec1_4'><title>Discussion</title><sec id='sec2_1'><title>Clinical Features</title><p><s sid='66'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>In the MCI stage, the best clinical predictor of the developing disease (DLB vs. AD) was presence of soft extrapyramidal signs, detected in 72% of DLB patients, followed by presence of RBD (60%) and fluctuations (60%).</s><s sid='67'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> These findings confirmed that some core features of DLB are already present before an overt dementia syndrome is manifested [<xref rid='B8' ref-type='bibr'>8</xref>].</s><s sid='68'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Moreover, 52% of MCI-DLB patients presented at the first assessment with 2 core features (fluctuation and extrapyramidal involvement).</s><s sid='69'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> However, these features may be underestimated since they could be very mild (very subtle motor involvement) or not sufficiently enquired (RBD and fluctuations).</s><s sid='70'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> On the other side, only 4 patients with AD had 1 core feature of DLB.</s><s sid='71'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> These data are in line with those reported in a neuropathology case series by Jicha et al. [<xref rid='B3' ref-type='bibr'>3</xref>], in which 8 of 9 patients with MCI developing brain pathological changes supportive of DLB had at least 1 symptom among the core features of DLB versus none of the MCI subjects developing later AD.</s></p><p><s sid='72'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>The study by Molano et al. [<xref rid='B2' ref-type='bibr'>2</xref>] underscores the importance to investigate symptoms and signs beyond cognition in the prodromal DLB stages and suggests that RBD may be the most sensitive predictor of developing DLB.</s><s sid='73'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> We confirm this statement, although in our study, the most frequent predictor of DLB was the presence of mild parkinsonism.</s><s sid='74'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Postuma et al. [<xref rid='B16' ref-type='bibr'>16</xref>] studied the development of parkinsonism in a cohort of patients with idiopathic RBD and demonstrated that motor changes, assessed with the UPDRS scale, were present for 6 years before the diagnosis of DLB, although with slow progression (UPDRS increase: 2 points per year).</s><s sid='75'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> They concluded that extrapyramidal signs in prodromal DLB have a more indolent course than in Parkinson's disease and proposed that this may be, at least in part, due to the involvement of extranigral structures.</s><s sid='76'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> In our study, extrapyramidal signs were subtle, mostly with a UPDRS motor score ≤5, suggesting the need to have a trained specialist to be intercepted.</s><s sid='77'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> It would be interesting to assess whether mild extrapyramidal signs detectable in AD patients, such as in the 4 subjects of this study, are due to the comorbid presence of α-synuclein pathology in the substantia nigra or whether they are caused by alterations of extranigral structures.</s><s sid='78'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> In a recent retrospective cohort study of 531 patients with neuropathological verification, AD with Lewy bodies had poorer motor performance and more behavioral problems than AD without Lewy bodies [<xref rid='B17' ref-type='bibr'>17</xref>].</s></p><p><s sid='79'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1>Although the main limitation of this study is the lack of autopsy confirmation, we are confident that the clinical diagnosis of DLB would have mirrored the neuropathological changes, since the likelihood of occurrence of the clinical syndrome of DLB has been found to be positively related to the extension of cortical Lewy bodies and negatively to neuritic pathology in AD [<xref rid='B18' ref-type='bibr'>18</xref>].</s></p></sec><sec id='sec2_2'><title>Cognitive Features</title><p><s sid='80'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>Prodromal AD showed a disproportionate involvement in long-term episodic memory, while prodromal DLB manifested a poorer verbal working memory (digit span backward) and a prominent difficulty in the speed and ease of verbal production (verbal fluency), as a consequence of more frontal/dysexecutive dysfunction.</s><s sid='81'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Our study supports the hypothesis that the visuoconstructional and object/space perception deficits typical of overt DLB are already present in the prodromal stage of the disease.</s><s sid='82'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> However, visuoconstructional and visual motor tracking deficits were more severe in early DLB patients than in AD, while visual-perceptual abilities investigated by the fragmented letters, silhouettes, object decision and progressive silhouettes items of the VOSP battery were impaired in both prodromal DLB and AD.</s><s sid='83'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> We were also able to demonstrate in prodromal DLB a specific impairment in number location and cube analysis, which rely on the ‘dorsal visual stream’, similarly to what Calderon et al. [<xref rid='B19' ref-type='bibr'>19</xref>] found in clinically manifested DLB.</s><s sid='84'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> In other words, the ventral visual pathway (‘what’) seems to be involved in the early stages in both DLB and AD, while functional impairment of the dorsal pathway (‘where’) is more specific of DLB.</s></p><p><s sid='85'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>Presence of visual-spatial/visuoconstructional deficits has been considered very common in autopsy-confirmed DLB patients at their first assessment [<xref rid='B20' ref-type='bibr'>20</xref>].</s><s sid='86'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The authors of this study proposed that the best model to predict DLB is the presence of visual hallucinations (positive predictive value: 83%), while lack of visual-spatial deficit represented a highly negative predictor of DLB (negative predictive value: 83%).</s><s sid='87'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> However, in this study the patients were demented (mean MMSE score 24 ± 4.2) and not in their prodromal stage.</s><s sid='88'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Our data referred to a disease stage antecedent to that described by Tiraboschi et al. [<xref rid='B20' ref-type='bibr'>20</xref>] and strengthened the previous finding by Ferman et al. [<xref rid='B1' ref-type='bibr'>1</xref>] which longitudinally followed a cohort of MCI-DLB patients describing a pattern of attentional and visuospatial involvement since the prodromal stage of the disease.</s><s sid='89'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> Although the retrospective nature of our study may be a limitation, it has the advantage to investigate the full spectrum of visual-spatial perception and attention by applying a specific cognitive battery.</s><s sid='90'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> As such, we were able to define that the visuoconstructional and spatial abilities are most specifically impaired in DLB, while object perception deficits, although very sensitive, are not specific cognitive signatures among DLB and AD in the prodromal stage.</s></p><p><s sid='91'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>The pentagon copying of the MMSE was first investigated in neuropathologically proven DLB and AD patients [<xref rid='B4' ref-type='bibr'>4</xref>].</s><s sid='92'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> In the study by Ala et al. [<xref rid='B4' ref-type='bibr'>4</xref>], 2 of 17 DLB patients and 17 of 26 AD patients drew the pentagons regularly (10 angles, of which 2 intersecting), reaching an 88% sensitivity and a 58% specificity in discriminating these two conditions.</s><s sid='93'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> However, the data referred to a group of patients in the full spectrum of disease severity, while in the earlier stages specificity could increase at the expense of sensitivity.</s></p><p><s sid='94'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>In an autopsy-proven study of pure AD (n = 66) and DLB (n = 9) patients, as opposed to the combination of AD and DLB (n = 57), it was demonstrated that pure AD patients performed worse in the verbal memory domain, while pure DLB patients presented spared verbal memory and a more altered visuospatial domain [<xref rid='B21' ref-type='bibr'>21</xref>].</s><s sid='95'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The AD/DLB comorbidity influences the cognitive pattern by further impairing only the visuospatial domain.</s><s sid='96'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Therefore, co-occurrence of DLB and AD pathology did not influence the speed of disease progression but only the type of cognitive impairment.</s><s sid='97'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> We acknowledge that the main limitation of our study is the lack of neuropathological confirmation and the impossibility to confirm the above-mentioned data.</s></p><p><s sid='98'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1>We found that prodromal DLB patients with reduced number of angles of the pentagon copy task, an index of altered visuoconstructional ability, have better verbal memory immediate recall scores than DLB patients with preserved number of angles.</s><s sid='99'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Hyp1' type='Hyp'></CoreSc1> We hypothesized that this subgroup of DLB patients may represent the pure form of DLB.</s><s sid='100'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> This suggestion is supported by the finding of Yoshizawa et al. [<xref rid='B22' ref-type='bibr'>22</xref>] that pure DLB patients have worse visuoconstructional deficits with respect to patients with AD and also mixed AD/DLB since the early stage of the disease.</s><s sid='101'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> The confirmation of clinical diagnosis by brain neuropathology will validate this hypothesis.</s></p></sec></sec><sec id='sec1_5'><title>Disclosure Statement</title><p>There are no conflicts of interest.</p></sec></body><back><ref-list><title>References</title><ref id='B1'><label>1</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Ferman</surname><given-names>TJ</given-names></name><name><surname>Smith</surname><given-names>GE</given-names></name><name><surname>Kantarci</surname><given-names>K</given-names></name><name><surname>Boeve</surname><given-names>BF</given-names></name><name><surname>Pankratz</surname><given-names>VS</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name><name><surname>Graff-Radford</surname><given-names>NR</given-names></name><name><surname>Wszolek</surname><given-names>Z</given-names></name><name><surname>Van Gerpen</surname><given-names>J</given-names></name><name><surname>Uitti</surname><given-names>R</given-names></name><name><surname>Pedraza</surname><given-names>O</given-names></name><name><surname>Murray</surname><given-names>ME</given-names></name><name><surname>Aakre</surname><given-names>J</given-names></name><name><surname>Parisi</surname><given-names>J</given-names></name><name><surname>Knopman</surname><given-names>DS</given-names></name><name><surname>Petersen</surname><given-names>RC</given-names></name></person-group><article-title>Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies</article-title><source>Neurology</source><year>2013</year><volume>81</volume><fpage>2032</fpage><lpage>2038</lpage><pub-id pub-id-type='pmid'>24212390</pub-id></element-citation></ref><ref id='B2'><label>2</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Molano</surname><given-names>J</given-names></name><name><surname>Boeve</surname><given-names>B</given-names></name><name><surname>Ferman</surname><given-names>T</given-names></name><name><surname>Smith</surname><given-names>G</given-names></name><name><surname>Parisi</surname><given-names>J</given-names></name><name><surname>Dickson</surname><given-names>D</given-names></name><name><surname>Knopman</surname><given-names>D</given-names></name><name><surname>Graff-Radford</surname><given-names>N</given-names></name><name><surname>Geda</surname><given-names>Y</given-names></name><name><surname>Lucas</surname><given-names>J</given-names></name><name><surname>Kantarci</surname><given-names>K</given-names></name><name><surname>Shiung</surname><given-names>M</given-names></name><name><surname>Jack</surname><given-names>C</given-names></name><name><surname>Silber</surname><given-names>M</given-names></name><name><surname>Pankratz</surname><given-names>VS</given-names></name><name><surname>Petersen</surname><given-names>R</given-names></name></person-group><article-title>Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study</article-title><source>Brain</source><year>2010</year><volume>133</volume><fpage>540</fpage><lpage>556</lpage><pub-id pub-id-type='pmid'>19889717</pub-id></element-citation></ref><ref id='B3'><label>3</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Jicha</surname><given-names>GA</given-names></name><name><surname>Schmitt</surname><given-names>FA</given-names></name><name><surname>Abner</surname><given-names>E</given-names></name><name><surname>Nelson</surname><given-names>PT</given-names></name><name><surname>Cooper</surname><given-names>GE</given-names></name><name><surname>Smith</surname><given-names>CD</given-names></name><name><surname>Markesbery</surname><given-names>WR</given-names></name></person-group><article-title>Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease</article-title><source>Neurobiol Aging</source><year>2010</year><volume>31</volume><fpage>1805</fpage><lpage>1813</lpage><pub-id pub-id-type='pmid'>19026468</pub-id></element-citation></ref><ref id='B4'><label>4</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Ala</surname><given-names>TA</given-names></name><name><surname>Hughes</surname><given-names>LF</given-names></name><name><surname>Kyrouac</surname><given-names>GA</given-names></name><name><surname>Ghobrial</surname><given-names>MW</given-names></name><name><surname>Elble</surname><given-names>RJ</given-names></name></person-group><article-title>Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's disease</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2001</year><volume>70</volume><fpage>483</fpage><lpage>488</lpage><pub-id pub-id-type='pmid'>11254771</pub-id></element-citation></ref><ref id='B5'><label>5</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Caffarra</surname><given-names>P</given-names></name><name><surname>Gardini</surname><given-names>S</given-names></name><name><surname>Dieci</surname><given-names>F</given-names></name><name><surname>Copelli</surname><given-names>S</given-names></name><name><surname>Maset</surname><given-names>L</given-names></name><name><surname>Concari</surname><given-names>L</given-names></name><name><surname>Farina</surname><given-names>E</given-names></name><name><surname>Grossi</surname><given-names>E</given-names></name></person-group><article-title>The qualitative scoring MMSE pentagon test (QSPT): a new method for differentiating dementia with Lewy body from Alzheimer's disease</article-title><source>Behav Neurol</source><year>2013</year><volume>27</volume><fpage>213</fpage><lpage>220</lpage><pub-id pub-id-type='pmid'>23396218</pub-id></element-citation></ref><ref id='B6'><label>6</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Caffarra</surname><given-names>P</given-names></name><name><surname>Vezzadini</surname><given-names>G</given-names></name><name><surname>Dieci</surname><given-names>F</given-names></name><name><surname>Zonato</surname><given-names>F</given-names></name><name><surname>Venneri</surname><given-names>A</given-names></name></person-group><article-title>Rey-Osterrieth complex figure: normative values in an Italian population sample</article-title><source>Neurol Sci</source><year>2002</year><volume>22</volume><fpage>443</fpage><lpage>447</lpage><pub-id pub-id-type='pmid'>11976975</pub-id></element-citation></ref><ref id='B7'><label>7</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Mitolo</surname><given-names>M</given-names></name><name><surname>Salmon</surname><given-names>DP</given-names></name><name><surname>Gardini</surname><given-names>S</given-names></name><name><surname>Galasko</surname><given-names>D</given-names></name><name><surname>Caffarra</surname><given-names>P</given-names></name></person-group><article-title>The new Qualitative Scoring MMSE Pentagon Test (QSPT) as a valid screening tool between autopsy-confirmed dementia with Lewy bodies and Alzheimer's disease</article-title><source>J Alzheimers Dis</source><year>2014</year><volume>39</volume><fpage>823</fpage><lpage>832</lpage><pub-id pub-id-type='pmid'>24284368</pub-id></element-citation></ref><ref id='B8'><label>8</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Cagnin</surname><given-names>A</given-names></name><name><surname>Bussè</surname><given-names>C</given-names></name><name><surname>Jelcic</surname><given-names>N</given-names></name><name><surname>Gnoato</surname><given-names>F</given-names></name><name><surname>Mitolo</surname><given-names>M</given-names></name><name><surname>Caffarra</surname><given-names>P</given-names></name></person-group><article-title>High specificity of MMSE pentagon scoring for diagnosis of prodromal dementia with Lewy bodies</article-title><source>Parkinsonism Relat Disord</source><year>2015</year><volume>21</volume><fpage>303</fpage><lpage>305</lpage><pub-id pub-id-type='pmid'>25547859</pub-id></element-citation></ref><ref id='B9'><label>9</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>McKeith</surname><given-names>IG</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name><name><surname>Lowe</surname><given-names>J</given-names></name><name><surname>Emre</surname><given-names>M</given-names></name><name><surname>O'Brien</surname><given-names>JT</given-names></name><name><surname>Feldman</surname><given-names>H</given-names></name><name><surname>Cummings</surname><given-names>J</given-names></name><name><surname>Duda</surname><given-names>JE</given-names></name><name><surname>Lippa</surname><given-names>C</given-names></name><name><surname>Perry</surname><given-names>EK</given-names></name><name><surname>Aarsland</surname><given-names>D</given-names></name><name><surname>Arai</surname><given-names>H</given-names></name><name><surname>Ballard</surname><given-names>CG</given-names></name><name><surname>Boeve</surname><given-names>B</given-names></name><name><surname>Burn</surname><given-names>DJ</given-names></name><name><surname>Costa</surname><given-names>D</given-names></name><name><surname>Del Ser</surname><given-names>T</given-names></name><name><surname>Dubois</surname><given-names>B</given-names></name><name><surname>Galasko</surname><given-names>D</given-names></name><name><surname>Gauthier</surname><given-names>S</given-names></name><name><surname>Goetz</surname><given-names>CG</given-names></name><name><surname>Gomez-Tortosa</surname><given-names>E</given-names></name><name><surname>Halliday</surname><given-names>G</given-names></name><name><surname>Hansen</surname><given-names>LA</given-names></name><name><surname>Hardy</surname><given-names>J</given-names></name><name><surname>Iwatsubo</surname><given-names>T</given-names></name><name><surname>Kalaria</surname><given-names>RN</given-names></name><name><surname>Kaufer</surname><given-names>D</given-names></name><name><surname>Kenny</surname><given-names>RA</given-names></name><name><surname>Korczyn</surname><given-names>A</given-names></name><name><surname>Kosaka</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>VM</given-names></name><name><surname>Lees</surname><given-names>A</given-names></name><name><surname>Litvan</surname><given-names>I</given-names></name><name><surname>Londos</surname><given-names>E</given-names></name><name><surname>Lopez</surname><given-names>OL</given-names></name><name><surname>Minoshima</surname><given-names>S</given-names></name><name><surname>Mizuno</surname><given-names>Y</given-names></name><name><surname>Molina</surname><given-names>JA</given-names></name><name><surname>Mukaetova-Ladinska</surname><given-names>EB</given-names></name><name><surname>Pasquier</surname><given-names>F</given-names></name><name><surname>Perry</surname><given-names>RH</given-names></name><name><surname>Schulz</surname><given-names>JB</given-names></name><name><surname>Trojanowski</surname><given-names>JQ</given-names></name><name><surname>Yamada</surname><given-names>M</given-names></name></person-group><article-title>Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium</article-title><source>Neurology</source><year>2005</year><volume>65</volume><fpage>1863</fpage><lpage>1872</lpage><pub-id pub-id-type='pmid'>16237129</pub-id></element-citation></ref><ref id='B10'><label>10</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>McKhann</surname><given-names>GM</given-names></name><name><surname>Knopman</surname><given-names>DS</given-names></name><name><surname>Chertkow</surname><given-names>H</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name><name><surname>Jack</surname><given-names>CRJ</given-names></name><name><surname>Kavas</surname><given-names>CH</given-names></name><name><surname>Klunk</surname><given-names>WE</given-names></name><name><surname>Koroshetz</surname><given-names>WJ</given-names></name><name><surname>Manly</surname><given-names>JJ</given-names></name><name><surname>Mayeux</surname><given-names>R</given-names></name><name><surname>Mohs</surname><given-names>RC</given-names></name><name><surname>Morris</surname><given-names>JC</given-names></name><name><surname>Rossor</surname><given-names>MN</given-names></name><name><surname>Scheltens</surname><given-names>P</given-names></name><name><surname>Carrillo</surname><given-names>MC</given-names></name><name><surname>Thies</surname><given-names>B</given-names></name><name><surname>Weintraub</surname><given-names>S</given-names></name><name><surname>Phelps</surname><given-names>CH</given-names></name></person-group><article-title>The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease</article-title><source>Alzheimers Dement</source><year>2011</year><volume>7</volume><fpage>263</fpage><lpage>269</lpage><pub-id pub-id-type='pmid'>21514250</pub-id></element-citation></ref><ref id='B11'><label>11</label><mixed-citation publication-type='other'><person-group person-group-type='author'><name><surname>Fahn</surname><given-names>S</given-names></name><name><surname>Elton</surname><given-names>RL</given-names></name><collab>Members of the Unified Parkinson's Disease Rating Scale Development Committee</collab></person-group> Unified Parkinson's disease rating scale; in Fahn S, Marsden CD, Calne DB, et al. (eds): Recent Developments in Parkinson's Disease. New York, McMillan Healthcare Information, 1987, pp 153-164.</mixed-citation></ref><ref id='B12'><label>12</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Cummings</surname><given-names>JL</given-names></name></person-group><article-title>The Neuropsychiatric Inventory: assessing psychopathology in dementia patients</article-title><source>Neurology</source><year>1997</year><volume>48</volume><fpage>S10</fpage><lpage>S16</lpage><pub-id pub-id-type='pmid'>9153155</pub-id></element-citation></ref><ref id='B13'><label>13</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Ferman</surname><given-names>TJ</given-names></name><name><surname>Smith</surname><given-names>GE</given-names></name><name><surname>Boeve</surname><given-names>BF</given-names></name><name><surname>Ivnik</surname><given-names>RJ</given-names></name><name><surname>Petersen</surname><given-names>RC</given-names></name><name><surname>Knopman</surname><given-names>D</given-names></name><name><surname>Graff-Radford</surname><given-names>N</given-names></name><name><surname>Parisi</surname><given-names>J</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name></person-group><article-title>DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging</article-title><source>Neurology</source><year>2004</year><volume>62</volume><fpage>181</fpage><lpage>187</lpage><pub-id pub-id-type='pmid'>14745051</pub-id></element-citation></ref><ref id='B14'><label>14</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Boeve</surname><given-names>BF</given-names></name><name><surname>Molano</surname><given-names>JR</given-names></name><name><surname>Ferman</surname><given-names>TJ</given-names></name><name><surname>Smith</surname><given-names>GE</given-names></name><name><surname>Lin</surname><given-names>SC</given-names></name><name><surname>Bieniek</surname><given-names>K</given-names></name><name><surname>Haidar</surname><given-names>W</given-names></name><name><surname>Tippmann-Peikert</surname><given-names>M</given-names></name><name><surname>Knopman</surname><given-names>DS</given-names></name><name><surname>Graff-Radford</surname><given-names>NR</given-names></name><name><surname>Lucas</surname><given-names>JA</given-names></name><name><surname>Petersen</surname><given-names>RC</given-names></name><name><surname>Silber</surname><given-names>MH</given-names></name></person-group><article-title>Validation of the Mayo Sleep Questionnaire to screen for REM sleep behaviour disorder in an aging and dementia cohort</article-title><source>Sleep Med</source><year>2011</year><volume>12</volume><fpage>445e53</fpage><pub-id pub-id-type='pmid'>21349763</pub-id></element-citation></ref><ref id='B15'><label>15</label><mixed-citation publication-type='other'><person-group person-group-type='author'><name><surname>Warrington</surname><given-names>EK</given-names></name><name><surname>James</surname><given-names>M</given-names></name></person-group> Visual Object and Space Perception Battery. Bury St Edmunds, Thames Valley Test Company, 1991.</mixed-citation></ref><ref id='B16'><label>16</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Postuma</surname><given-names>RB</given-names></name><name><surname>Lang</surname><given-names>AE</given-names></name><name><surname>Gagnon</surname><given-names>JF</given-names></name><name><surname>Pelletier</surname><given-names>A</given-names></name><name><surname>Montplaisir</surname><given-names>JY</given-names></name></person-group><article-title>How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder</article-title><source>Brain</source><year>2012</year><volume>135</volume><fpage>1860</fpage><lpage>1870</lpage><pub-id pub-id-type='pmid'>22561644</pub-id></element-citation></ref><ref id='B17'><label>17</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Chung</surname><given-names>EJ</given-names></name><name><surname>Babulal</surname><given-names>GM</given-names></name><name><surname>Monsell</surname><given-names>SE</given-names></name><name><surname>Cairns</surname><given-names>NJ</given-names></name><name><surname>Roe</surname><given-names>CM</given-names></name><name><surname>Morris</surname><given-names>JC</given-names></name></person-group><article-title>Clinical features of Alzheimer disease with and without Lewy bodies</article-title><source>JAMA Neurol</source><year>2015</year><volume>72</volume><fpage>789</fpage><lpage>796</lpage><pub-id pub-id-type='pmid'>25985321</pub-id></element-citation></ref><ref id='B18'><label>18</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Tiraboschi</surname><given-names>P</given-names></name><name><surname>Attems</surname><given-names>J</given-names></name><name><surname>Thomas</surname><given-names>A</given-names></name><name><surname>Brown</surname><given-names>A</given-names></name><name><surname>Jaros</surname><given-names>E</given-names></name><name><surname>Lett</surname><given-names>DJ</given-names></name><name><surname>Ossola</surname><given-names>M</given-names></name><name><surname>Perry</surname><given-names>RH</given-names></name><name><surname>Ramsay</surname><given-names>L</given-names></name><name><surname>Walker</surname><given-names>L</given-names></name><name><surname>McKeith</surname><given-names>IG</given-names></name></person-group><article-title>Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid load</article-title><source>Neurology</source><year>2015</year><volume>84</volume><fpage>496</fpage><lpage>499</lpage><pub-id pub-id-type='pmid'>25552579</pub-id></element-citation></ref><ref id='B19'><label>19</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Calderon</surname><given-names>J</given-names></name><name><surname>Perry</surname><given-names>RJ</given-names></name><name><surname>Erzinclioglu</surname><given-names>SW</given-names></name><name><surname>Berrios</surname><given-names>GE</given-names></name><name><surname>Dening</surname><given-names>TR</given-names></name><name><surname>Hodges</surname><given-names>JR</given-names></name></person-group><article-title>Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease</article-title><source>Neurol Neurosurg Psychiatry</source><year>2001</year><volume>70</volume><fpage>157</fpage><lpage>164</lpage></element-citation></ref><ref id='B20'><label>20</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Tiraboschi</surname><given-names>P</given-names></name><name><surname>Salmon</surname><given-names>DP</given-names></name><name><surname>Hansen</surname><given-names>LA</given-names></name><name><surname>Hofstetter</surname><given-names>RC</given-names></name><name><surname>Thal</surname><given-names>LJ</given-names></name><name><surname>Corey-Bloom</surname><given-names>J</given-names></name></person-group><article-title>What best differentiates Lewy body from Alzheimer's disease in early-stage dementia?</article-title><source>Brain</source><year>2006</year><volume>129</volume><fpage>729</fpage><lpage>735</lpage><pub-id pub-id-type='pmid'>16401618</pub-id></element-citation></ref><ref id='B21'><label>21</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Johnson</surname><given-names>DK</given-names></name><name><surname>Morris</surname><given-names>JC</given-names></name><name><surname>Galvin</surname><given-names>JE</given-names></name></person-group><article-title>Verbal and visuospatial deficits in dementia with Lewy bodies</article-title><source>Neurology</source><year>2005</year><volume>65</volume><fpage>1232</fpage><lpage>1238</lpage><pub-id pub-id-type='pmid'>16247050</pub-id></element-citation></ref><ref id='B22'><label>22</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Yoshizawa</surname><given-names>H</given-names></name><name><surname>Vonsattel</surname><given-names>JPG</given-names></name><name><surname>Honig</surname><given-names>LS</given-names></name></person-group><article-title>Early neuropsychological discriminants for Lewy body disease: an autopsy series</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2013</year><volume>84</volume><fpage>1326</fpage><lpage>1330</lpage><pub-id pub-id-type='pmid'>23308020</pub-id></element-citation></ref></ref-list></back><floats-group><fig orientation='portrait' id='F1' position='float'><label>Fig. 1</label><caption><p>Mean percentage of correct scores for the VOSP subtests in MCI-DLB (light gray columns) and AD (dark gray columns).</p></caption><graphic xlink:href='dee-0005-0442-g01'></graphic></fig><table-wrap orientation='portrait' id='T1' position='float'><label>Table 1</label><caption><p>Cognitive tests score differences between prodromal DLB and AD patients</p></caption><table rules='groups' frame='hsides'><thead><tr valign='top'><th colspan='1' rowspan='1' align='left'>Cognitive tests</th><th colspan='1' rowspan='1' align='left'>Prodromal DLB (n = 25)</th><th colspan='1' rowspan='1' align='left'>Prodromal AD (n = 28)</th><th colspan='1' rowspan='1' align='left'>p</th></tr></thead><tbody><tr><td colspan='1' rowspan='1' align='left'>MMSE</td><td colspan='1' rowspan='1' align='left'>27.8 ± 1.3</td><td colspan='1' rowspan='1' align='left'>27.2 ± 1.3</td><td colspan='1' rowspan='1' align='left'>0.07</td></tr><tr><td colspan='1' rowspan='1' align='left'>QSPT</td><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1'></td></tr><tr><td colspan='1' rowspan='1' align='left'> Total score</td><td colspan='1' rowspan='1' align='left'>10.8 ± 2.1</td><td colspan='1' rowspan='1' align='left'>11.6 ± 1.2</td><td colspan='1' rowspan='1' align='left'>0.1</td></tr><tr><td colspan='1' rowspan='1' align='left'> Number of angles</td><td colspan='1' rowspan='1' align='left'>3.28 ± 1.1</td><td colspan='1' rowspan='1' align='left'>3.96 ± 0.2</td><td colspan='1' rowspan='1' align='left'><bold>0.01</bold></td></tr><tr><td colspan='1' rowspan='1' align='left'>Number of angles &lt;4, %</td><td colspan='1' rowspan='1' align='left'>44</td><td colspan='1' rowspan='1' align='left'>3.7</td><td colspan='1' rowspan='1' align='left'><bold>&lt;0.001</bold></td></tr><tr><td colspan='1' rowspan='1' align='left'>Digit cancellation</td><td colspan='1' rowspan='1' align='left'>41.8 ± 8.2</td><td colspan='1' rowspan='1' align='left'>43.7 ± 9.1</td><td colspan='1' rowspan='1' align='left'>0.56</td></tr><tr><td colspan='1' rowspan='1' align='left'>Trail Making Test A, s</td><td colspan='1' rowspan='1' align='left'>99 ± 70.8</td><td colspan='1' rowspan='1' align='left'>66.4 ± 28</td><td colspan='1' rowspan='1' align='left'><bold>0.03</bold></td></tr><tr><td colspan='1' rowspan='1' align='left'>Digit span</td><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1'></td></tr><tr><td colspan='1' rowspan='1' align='left'> Forward</td><td colspan='1' rowspan='1' align='left'>4.7 ± 1</td><td colspan='1' rowspan='1' align='left'>5.1 ± 0.8</td><td colspan='1' rowspan='1' align='left'>0.1</td></tr><tr><td colspan='1' rowspan='1' align='left'> Backward</td><td colspan='1' rowspan='1' align='left'>3.0 ± 1.2</td><td colspan='1' rowspan='1' align='left'>3.9 ± 0.6</td><td colspan='1' rowspan='1' align='left'><bold>0.001</bold></td></tr><tr><td colspan='1' rowspan='1' align='left'>Prose memory</td><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1'></td></tr><tr><td colspan='1' rowspan='1' align='left'> Immediate recall</td><td colspan='1' rowspan='1' align='left'>10.7 ± 4.6</td><td colspan='1' rowspan='1' align='left'>8.2 ± 5.9</td><td colspan='1' rowspan='1' align='left'>0.08</td></tr><tr><td colspan='1' rowspan='1' align='left'> Delayed recall</td><td colspan='1' rowspan='1' align='left'>11.4 ± 5.8</td><td colspan='1' rowspan='1' align='left'>7.7 ± 5.4</td><td colspan='1' rowspan='1' align='left'><bold>0.02</bold></td></tr><tr><td colspan='1' rowspan='1' align='left'>Verbal fluency</td><td colspan='1' rowspan='1' align='left'>22.3 ± 10.1</td><td colspan='1' rowspan='1' align='left'>30.5 ± 9</td><td colspan='1' rowspan='1' align='left'><bold>0.002</bold></td></tr><tr><td colspan='1' rowspan='1' align='left'>ROCF</td><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1'></td></tr><tr><td colspan='1' rowspan='1' align='left'> Copy</td><td colspan='1' rowspan='1' align='left'>27.1 ± 4.9</td><td colspan='1' rowspan='1' align='left'>31.1 ± 7.2</td><td colspan='1' rowspan='1' align='left'>0.05</td></tr><tr><td colspan='1' rowspan='1' align='left'> Delayed recall</td><td colspan='1' rowspan='1' align='left'>8.9 ± 4.5</td><td colspan='1' rowspan='1' align='left'>8.6 ± 5.4</td><td colspan='1' rowspan='1' align='left'>1</td></tr><tr><td colspan='1' rowspan='1' align='left'>VOSP</td><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1'></td></tr><tr><td colspan='1' rowspan='1' align='left'> Visual perception</td><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1'></td></tr><tr><td colspan='1' rowspan='1' align='left'> Fragmented letters (cutoff &gt;16)</td><td colspan='1' rowspan='1' align='left'>16.7 ± 4.2</td><td colspan='1' rowspan='1' align='left'>17.3 ± 3.7</td><td colspan='1' rowspan='1' align='left'>0.51</td></tr><tr><td colspan='1' rowspan='1' align='left'> Silhouettes (cutoff &gt;15)</td><td colspan='1' rowspan='1' align='left'>13.9 ± 7.2</td><td colspan='1' rowspan='1' align='left'>15.2 ± 5.1</td><td colspan='1' rowspan='1' align='left'>0.31</td></tr><tr><td colspan='1' rowspan='1' align='left'> Object decision (cutoff &gt;14)</td><td colspan='1' rowspan='1' align='left'>12.6 ± 3.1</td><td colspan='1' rowspan='1' align='left'>14.6 ± 3.8</td><td colspan='1' rowspan='1' align='left'>0.05</td></tr><tr><td colspan='1' rowspan='1' align='left'> Progressive silhouettes (cutoff &gt;15)</td><td colspan='1' rowspan='1' align='left'>11.9 ± 2.3</td><td colspan='1' rowspan='1' align='left'>11.8 ± 2.6</td><td colspan='1' rowspan='1' align='left'>0.96</td></tr><tr><td colspan='1' rowspan='1' align='left'> Spatial perception</td><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1'></td></tr><tr><td colspan='1' rowspan='1' align='left'> Dot counting (cutoff ≥8)</td><td colspan='1' rowspan='1' align='left'>9.4 ± 0.7</td><td colspan='1' rowspan='1' align='left'>9.6 ± 1.3</td><td colspan='1' rowspan='1' align='left'>0.81</td></tr><tr><td colspan='1' rowspan='1' align='left'> Position discrimination (cutoff ≥18)</td><td colspan='1' rowspan='1' align='left'>18.5 ± 1.8</td><td colspan='1' rowspan='1' align='left'>19.1 ± 1.8</td><td colspan='1' rowspan='1' align='left'>0.25</td></tr><tr><td colspan='1' rowspan='1' align='left'> Number location (cutoff ≥7)</td><td colspan='1' rowspan='1' align='left'>7.6 ± 1.8</td><td colspan='1' rowspan='1' align='left'>8.9 ± 2.5</td><td colspan='1' rowspan='1' align='left'><bold>0.03</bold></td></tr><tr><td colspan='1' rowspan='1' align='left'> Cube analysis (cutoff ≥6)</td><td colspan='1' rowspan='1' align='left'>7.3 ± 2</td><td colspan='1' rowspan='1' align='left'>8.8 ± 2.2</td><td colspan='1' rowspan='1' align='left'><bold>&lt;0.001</bold></td></tr></tbody></table><table-wrap-foot><fn><p>Data are presented as mean ± SD except where indicated otherwise. Bold p values indicate statistical significance.</p></fn></table-wrap-foot></table-wrap></floats-group></article></PAPER>